 |
Yahoo! News :: Health |
Two drugs don't boost lung cancer survival: Roche (Reuters)Reuters - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.View full item |
|
Go to syndication wizard for this feed Go to the history for this feed Go to the archive for this feed |
| Home | Syndication wizard | Contact us |
| Webhosting by VDX · Copyright © 2007-2008 FeedFan / Feed Folder |
| Other websites: CitySite · Favos · FeedFolder · FinPo · Starten |